Obstetric & Gynecology

First-trimester screening has three parts, an ultrasound test for fetal nuchal translucency (NT), PAPP-A, and hCG. When used together, NT screening and maternal blood tests have a greater ability to determine if the fetus might have a birth defect, such as Down syndrome, Edward syndrome, or Patau syndrome. Additional testing, such as amniocentesis or other ultrasound procedures, may be necessary for accurate diagnosis if the results are abnormal.

HPV is short for human papillomavirus, a very common sexually transmitted infection divided into different types, each identified with a number. HPV types including 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 are high-risk types known to significantly increase the risk of cervical, vaginal, and vulvar cancer in women, as well as penile cancer in men. These types can also cause anal cancer and throat cancers in men and women.

HPV is short for human papillomavirus, a very common sexually transmitted infection divided into different types, each identified with a number. High-risk HPVs (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) can cause several types of cancer. Two of these, HPV16 and HPV18, are responsible for most HPV-related cancers. Low-risk HPVs are mostly asymptomatic. Sometimes, these types can cause warts on or around the genitals, anus, mouth, or throat.

Pap smear is a method that a health care provider collects cells from the cervix and sends them to a lab. At the lab, the cells are checked under a microscope for cancer or for signs that they may become cancer. This sample is also checked for HPV, a virus that can cause cervical cancer. Pap smears and HPV tests are cervical cancer screening tests that look for cancer before you have any symptoms.

Pathtezt is intended as a replacement for the conventional method of Pap smear tests in screening for atypical cells, cervical cancer, or its precursor lesions (LSIL, HSIL). These smears are high-quality and cost-effective.

Pathtezt is intended as a replacement for the conventional method of Pap smear tests in screening for atypical cells, cervical cancer, or its precursor lesions (LSIL, HSIL). These smears are high-quality and cost-effective.

Preeclampsia is a high blood pressure (hypertension) disorder that can occur after the 20th week of pregnancy. Complications of preeclampsia may include fetal growth restriction, preterm birth, and placental abruption. The PlGF assay is used with the sFlt-1 assay, other diagnostic tests, and clinical information to diagnose preeclampsia.